Typhoid vaccination: the Asian experience

References

• Crump JA, Luby SP, Minta ED. The global burden of typhoid fever. Bull. World Health Organ.82(5), 346–353 (2004).
   PubMed Web of Science ®Google Scholar
• Ochiai RL, Acosta CJ, Danovaro-Holliday MC et al. A study of typhoid fever in five Asian countries: disease burden and implications for control. Bull. World Health Organ.86(4), 260–268 (2008).
   PubMed Web of Science ®Google Scholar
• Steffen R, Rickenbach M, Wilhelm U, Helminger A, Schar M. Health problems after travel to developing countries. J. Infect. Dis.156, 84–91 (1987).
   PubMed Web of Science ®Google Scholar
• Lawrence J, Jones J. Final Report: Pilot of Enhanced Enteric Fever Surveillance in England, Wales, and Northern Ireland 2008. Health Protection Agency, London, UK (2008).
   Google Scholar
• Guzman CA, Borsutzky S, Grio-Wenk M et al. Vaccines against typhoid fever. Vaccine24, 3804–3811 (2006).
   PubMed Web of Science ®Google Scholar
• Levine MM. Typhoid fever vaccines. In: Vaccines (3rd Edition). Plotkin AS, Orenstein WA (Eds). WB Saunders, PA, USA 781–814 (1999).
   Google Scholar
• Ivanoff B, Levine MM, Lambert PH. Vaccination against typhoid fever: present status. Bull. World Health Organ.72(6), 957–791 (1994).
   PubMed Web of Science ®Google Scholar
• Klugman KP, Koornhof HJ, Robbins JB, Bouveret LE, Cam NN. Immunogenicity, efficacy and serological correlative of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine14, 435–438 (1996).
   PubMed Web of Science ®Google Scholar
• Wain J, Kidgell C. The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever. Trans. R. Soc. Trop. Med. Hyg.98, 423–430 (2004).
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO report to the Scientific Advisory Group of Experts (SAGE). WHO/GPV/98.06 (1998).
   Google Scholar
• World Health Organization. Typhoid vaccines: WHO position paper. Wkly Epidemiol. Rec.75, 257–264 (2000).
   PubMedGoogle Scholar
• Lin FY, Ho VA, Khiem HB et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N. Engl. J. Med.344(17), 1263–1269 (2001).
   PubMed Web of Science ®Google Scholar
• Kirkpatrick BD, McKenzie R, O’Neill JP et al. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine24(2), 116–123 (2006).
   PubMed Web of Science ®Google Scholar
• Wahid R, Salerno-Gonçalves R, Tacket CO, Levine MM, Sztein MB. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. Vaccine25(8), 1416–1425 (2007).
   PubMed Web of Science ®Google Scholar
• World Health Organization. Typhoid vaccines: WHO position paper. Wkly Epidemiol. Rec.83, 49–60 (2008).
   PubMedGoogle Scholar
• Yang HH, Kilgore PE, Yang LH et al. An outbreak of typhoid fever, Xing-An county, People’s Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. J. Infect. Dis.183, 1775–1780 (2001).
   PubMedGoogle Scholar
• Bodhidatta L, Taylor DN, Thisyakorn U, Echeverria P. Control of typhoid fever in Bangkok, Thailand, by annual immunization of school children with parenteral typhoid vaccine. Rev. Infect. Dis.9(4), 841–845 (1987).
   PubMedGoogle Scholar
• Yang HH, Wu CG, Xie GZ et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in southwestern China. Bull. World Health Organ.79(7), 625–631 (2001).
   PubMed Web of Science ®Google Scholar
• Yang HH. Experience of school-based vaccination in a typhoid fever endemic area using Vi manufactured in China. Presented at: Typhoid Fever, a Neglected Disease: Towards a Vaccine Introduction Policy. Annecy, France, 2–4 April, 2007.
   Google Scholar
• Lin M, Gong J, Li C, Liang D, Liao H. [Analysis of diagnosis evidence for notifiable cases with typhoid or paratyphoid fever and strategic research in Guangxi]. J. Guangxi Prev. Med.10(6), 327–329 (2004).
   Google Scholar
• Sinha A, Sazawal S, Kumar R et al. Typhoid fever in children aged less than 5 years. Lancet354, 734–737 (1999).
   PubMed Web of Science ®Google Scholar
• Clemens JD, Brenner R, Rao M, Tafari N, Lowe C. Evaluating new vaccines for developing countries: efficacy or effectiveness? JAMA, 275(5), 390–397 (1996).
   PubMed Web of Science ®Google Scholar
• Acosta CJ, Galindo CM, Ali M et al. A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design. Trop. Med. Int. Health10(12), 1219–1228 (2005).
   PubMedGoogle Scholar
• Kaljee LM, Pham V, Son ND et al. Trial participation and vaccine desirability for Vi polysaccharide typhoid fever vaccine in Hue city, Viet Nam. Trop. Med. Int. Health12(1), 25–36 (2007).
   PubMed Web of Science ®Google Scholar
• Thiem VD, Danovaro-Holliday MC, Canh DG et al. The feasibility of a school-based Vi polysaccharide vaccine mass immunization campaign in Hue City, Central Vietnam: streamlining a typhoid fever preventive strategy. Southeast Asian J. Trop. Med. Public Health37(3), 1–8 (2006).
   Google Scholar
• Steinberg EB, Bishop R, Haber P et al. Typhoid fever in travelers: who should be targeted for prevention? Clin. Infect. Dis.39(2), 186–191 (2004).
   PubMed Web of Science ®Google Scholar
• Lin FYC, Ho VA, Bay PV et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am. J. Trop. Med. Hyg.62(5), 644–648 (2000).
   PubMed Web of Science ®Google Scholar
• Levine MM, Ferreccio C, Black RE, Tacket CO, Germainier R; Chilean Typhoid Committee. Progress in vaccines against typhoid fever. Rev. Infect. Dis.11(Suppl. 3), S552–S567 (1989).
   PubMedGoogle Scholar
• Ochiai RL, Wang XY, von Seidlein L et al.Salmonella Paratyphi A rates, Asia. Emerg. Inf. Dis.11(11), 1764–1766 (2005).
   PubMed Web of Science ®Google Scholar
• Levine MM, Ferreccio C, Black RE, Lagos R, San Martin O, Blackwelder WC. Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica serovar Paratyphi B. Clin. Infect. Dis.45(Suppl. 1), S24–S28 (2007).
   PubMed Web of Science ®Google Scholar